NMNH or dihydronicotinamide mononucleotide is a reduced form of NMN that has demonstrated the potential to surpass conventional NAD+ precursors in terms of efficacy in cellular health enhancement.

NAD+ precursors in an oxidized form, such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR), have gained much attention and have been well-studied for their ability to restore NAD+ levels in model organisms.

NMNH is better at raising NAD+ levels quickly and more effectively than NMN or NR. NMNH uses a different pathway in the body to increase NAD+ levels, which doesn’t rely on the usual enzymes (NRK and NAMPT) that NMN and NR depend on.

Key Features :

+ Remarkable stability – low hygroscopicity, less degradation
+ Ultrapure NMNH with 99%  min. purity by HPLC 
+ Non-GMO, Gluten-free, Vegan friendly